Floatz logo

Plerixafor

Multiple Myeloma and Malignant Lymphoma

Kyowa Kirin Co., Ltd.Small moleculePhase 2Active
B
56/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
41/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the Multiple Myeloma and Malignant Lymphoma cohort.

Asset / SponsorPhaseRating
FILGRASTIM
Kyowa Kirin Co., Ltd.
Phase 2B
PEGFILGRASTIM
Kyowa Kirin Co., Ltd.
Phase 2B

Same molecule, other indications

Plerixafor is also rated in:

Fanconi anemiaDormant
BB
Indicative ·
70 / 100
View asset →
Hodgkins lymphomaDormant
BB
Indicative ·
70 / 100
View asset →
non-Hodgkin lymphomaDormant
BB
Indicative ·
69 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →